The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

View the CDDF’s interviews with participants at the CDDF Annual Conference 2024 (5 – 7 February 2024, Noordwijk) and gain valuable perspectives on key topics in oncology from diverse stakeholders.

Continued dialogue and collaboration is key to the development and delivery of effective treatment for cancer patients.

👏 🥇 Special thanks to our interviewees for their meaningful engagement and inputs:
Francesco Pignatti (EMA,NL), Richard Price (European Cancer Organisation, BE), Jacqueline Daly (East Galway & Midlands Cancer Support, IR), Ruth Curley (Ryvu, PL), Peter Mol (University Medical Center Groningen, NL), Katrin Rupalla (Johnson & Johnson, CH), Debbie Keatley (Independent Cancer Patients’ Voice, UK), & Dana Gabriela Marin (National Agency for Medicines and Medical Devices of Romania)

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70